Advisor Group Holdings, Inc. P Lx Pharma Inc. Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.15 - $0.63 $240 - $1,008	1,600 Added 30.48%	6,850 $1,000
Q3 2022 Nov 14, 2022	BUY	$0.52 - $3.08 $182 - $1,078	350 Added 7.14%	5,250 $3,000
Q2 2022 Aug 10, 2022	BUY	$1.9 - $4.18 $5,272 - $11,599	2,775 Added 130.59%	4,900 $12,000
Q1 2022 May 04, 2022	BUY	$3.54 - $8.3 $2,212 - $5,187	625 Added 41.67%	2,125 $8,000
Q2 2021 Aug 02, 2021	BUY	$9.0 - $15.94 $13,500 - $23,910	1,500 New	1,500 $21,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.